Potential Pivot From Portfolio Valuations to ER?
Hi all!
Currently a first-year analyst in the Portfolio Valuation team for one of the largest HFs/PEs in the world. Have experience working with OPM, Multiples Analysis, Transaction Comps, and DCFs across the TMT and Healthcare space as well as running management calls and internal valuation committee meetings. With that being said, I am looking to change the pace and potentially pivot into a sell-side Equity Research capacity. What are the chances of being able to do this? If material, what steps should I take in accomplishing this? Moreover, I do have buy-side credit/CLO internship experience.
Happy to chat in PMs if that works as well. Thank you all!
Incidunt molestiae molestias praesentium quibusdam hic eveniet at enim. Animi voluptas a aliquam perferendis. Quo quam reprehenderit nostrum autem et at voluptatem. Dignissimos nostrum ad aspernatur quos. Minus dolorem ut aut voluptatum fugiat. Expedita eius expedita illo natus in neque. Iusto atque harum minus commodi error voluptatem.
Laborum et non illum aut similique qui vitae. Voluptatum quasi soluta impedit aut debitis omnis hic.
Vero eveniet voluptatem aut architecto ea. Qui molestiae fugiat maiores nihil blanditiis cupiditate in. Fugiat dolores vel provident ea at praesentium. Id quia consequatur distinctio eos laudantium voluptatem. Voluptatem laboriosam est repellat. Alias reiciendis sunt qui quia.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...